News Updates

Pinecrest Healthcare ltd, in partnership with Biorad laboratories USA, successfully completed the supply and installation of Variant nbs (HPLC) Systems to four federal tertiary care centers across Nigeria. The centers are:

Read More

Pinecrest Healthcare Ltd participates in Medic West Africa Health fair

Read More

Pinecrest completes the supply and installation of Variant nbs (HPLC) System to 2 additional centers in Nigeria

Read More

Pinecrest Healthcare Ltd made more in-roads with Biroad HPLC Sytems

Read More

Pinecrest Healthcare – partnership with Biorad Laboratories – sponsored this year’s world sickle cell day celebration.

Read More

Attention: open in a new window. PDFPrintE-mail




The VARIANTnbs is the established worldwide standard in automated newborn screening for sickle cell disease and other hemoglobin disorders. It features fully automated analysis and advanced result reporting for maximum efficiency. Using dried blood spot specimens, the VARIANTnbs identifies the most clinically significant hemoglobin variants, including hemoglobins F, S, A, C, D and E, as well as the carrier status for abnormal hemoglobin variants and many double-heterozygote conditions. The VARIANTnbs provides the total hemoglobin picture.

The VARIANTnbs is specifically designed for high-capacity screening and walk-away automation, reducing labor requirements and human error. Load up to three systems per workstation and up to 1,128 samples per run. Smart reports with optional pattern rules simplify data review while providing objective, accurate results. A flexible worklist import function eliminates file incompatibility issues. Reviewing and managing results is simple with electronic chromatogram storage and retrieval.






Reagents, supplies for 1000 hemoglobin S, F, A, C, D, E tests of newborn dried blood using VARIANTnbs System; aids detection of abnormal hemoglobin.